Drug Pipeline Pulse Check: Landmark Approval for Dendreon
DENDREON Corp (DNDN) The FDA’s landmark approval of Dendreon’s prostate cancer vaccine, Provenge, has been warmly welcomed by analysts. After being rejected three years ago, the approval of the drug marks a significant breakthrough for cancer treatment and research. The vaccine, which allows a patient to use their own immune system to fight the disease, [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here